Difficulty: Medium
Average Score: 72%
Practice
A patient is being administered chemotherapeutic agents for the treatment of cancer. Which of the following blood cells will be stimulated by the colony-stimulating factors in response to the effects of the chemotherapy?
Correct answer
A
Rationale
In the context of chemotherapy, colony-stimulating factors play a crucial role in stimulating the production of white blood cells (leukocytes) in the bone marrow. White blood cells are essential components of the immune system and are particularly important in fighting infections. Chemotherapy often suppresses bone marrow function, leading to decreased levels of white blood cells, which can increase the risk of infections. Colony-stimulating factors help to counteract this effect by promoting the production of white blood cells, thereby supporting the immune system.
In this scenario, option A (White blood cells) is the correct answer because colony-stimulating factors are specifically designed to stimulate the production of these cells. Red blood cells (option B) are not directly affected by colony-stimulating factors in response to chemotherapy. Phagocytes (option C) are a type of white blood cell involved in engulfing and destroying pathogens but are not the primary target of colony-stimulating factors. Myocardial cells (option D) are cardiac muscle cells and are not directly involved in the immune response to chemotherapy.
It is crucial for healthcare professionals to understand the impact of chemotherapy on different blood cells and the role of colony-stimulating factors in maintaining the immune system during cancer treatment. By recognizing the specific effects of chemotherapy on blood cell production, healthcare providers can better manage potential complications such as infections in patients undergoing cancer treatment.
In this scenario, option A (White blood cells) is the correct answer because colony-stimulating factors are specifically designed to stimulate the production of these cells. Red blood cells (option B) are not directly affected by colony-stimulating factors in response to chemotherapy. Phagocytes (option C) are a type of white blood cell involved in engulfing and destroying pathogens but are not the primary target of colony-stimulating factors. Myocardial cells (option D) are cardiac muscle cells and are not directly involved in the immune response to chemotherapy.
It is crucial for healthcare professionals to understand the impact of chemotherapy on different blood cells and the role of colony-stimulating factors in maintaining the immune system during cancer treatment. By recognizing the specific effects of chemotherapy on blood cell production, healthcare providers can better manage potential complications such as infections in patients undergoing cancer treatment.